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Abstract
Background: Despite a well-recognised burden of disabling physical symptoms compounded by co-morbidities,
psychological distress and social isolation, the needs of people with severe chronic obstructive pulmonary disease (COPD)
are typically poorly addressed.
Aim: To assess the effectiveness of interventions designed to deliver holistic care for people with severe COPD.
Methods: We searched 11 biomedical databases, three trial repositories (January 1990-March 2012; no language
restrictions) and contacted international experts to locate published, unpublished and in-progress randomised controlled
trials (RCTs), quasi-RCTs and controlled clinical trials (CCTs) that investigated holistic interventions to support patients with
severe COPD in any healthcare context. The primary outcome was health-related quality of life (HRQoL). Quality assessment
and data extraction followed Cochrane Collaboration methodology. We used a piloted data extraction sheet and undertook
narrative synthesis.
Results: From 2,866 potentially relevant papers, we identified three trials: two RCTs (from United States and Australia), and
one CCT (from Thailand): total 216 patients. Risk of bias was assessed as moderate in two studies and high in the third. All
the interventions were led by nurses acting in a co-ordinating role (e.g. facilitating community support in Thailand,
providing case-management in the USA, or co-ordinating inpatient care in Australia). HRQoL improved significantly in the
Thai CCT compared to the (very limited) usual care (p,0.001), in two sub-domains in the American trial, but showed no
significant changes in the Australian trial. Exercise tolerance, dyspnoea, and satisfaction with care also improved in the Thai
trial.
Conclusions: Some 15 years after reports first highlighted the unmet needs of people with severe COPD, we have been
unable to find robust trial evidence about interventions that can address those needs. There is an urgent need to develop
and evaluate holistic care interventions designed improve HRQoL for people with severe COPD.
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Introduction
Globally, long-term conditions such as chronic obstructive
pulmonary disease (COPD) are responsible for increasing mor-
bidity and an increasing proportion of deaths. [1] People with
severe COPD have a well-recognised burden of disabling physical
symptoms (especially breathlessness), psychological distress and
social isolation, [2,3,4,5,6] often more severe than people with
lung cancer. [2] Despite this the clinical and social care needs of
these patients, usually compounded by co-morbidities, are
typically poorly addressed; [2,3] leading to calls for equity of
access to supportive care services. [7,8]
The current approach is to build on existing cancer-based
palliative care services, [7,9] which are predicated on an ability to
recognise a terminal phase, [10,11] when physical, psychological,
social and spiritual needs can be assessed and holistic care
planned. [11,12] Despite defined prognostic indicators, [13,14]
accurate prognostication for individuals with COPD remains
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extremely difficult, [12,15] raising concerns that inability to
identify people at risk of dying may act as a barrier to provision of
care. [16] A further challenge is the recognised tendency for
people with COPD to remain ‘silent’ about their (often very
considerable) physical and social disabilities. [17] People with end-
stage COPD tend to ‘normalise’ their limitations as the result of
‘old age’, [18] about which ‘nothing can be done’[17] and may be
slow to acknowledge end of life concerns [19]. ‘Weary resignation’
after years of futile attempts to improve their circumstances, [20]
and/or a ‘recalibration’ of expectations [21] as an adaptive coping
strategy may contribute to an undemanding acceptance of their
circumstances by patients and their family carers.
Our recent multi-perspective longitudinal qualitative study
described the lifelong story of COPD. [22] Significantly for the
development of models of care towards the end of life, our data
suggested that a ‘clear point of transition’ to palliative care was
meaningless in a condition with no clear beginning and an
unpredictable, unanticipated end. Instead, we concluded that
physical, psychological, social and spiritual needs should be sought
proactively, and palliation of symptoms and holistic supportive
care intensified according to need, without any formal require-
ment to identify end-stage disease.
We sought systematically to identify and critically appraise
published and unpublished clinical trials that assessed the
effectiveness of interventions designed to deliver or enhance
holistic care (i.e. addressing physical, psychological, social and
spiritual needs) compared to usual care in any healthcare system
for people with severe COPD.
Methods
Our systematic review is registered with PROSPERO
(CRD42012002430). We made no substantial amendments to
the online protocol. [23] We followed the procedures described in
the Cochrane Handbook for Systematic Reviews of Interventions
[24] and the PRISMA statement for reporting systematic reviews.
[25]
Inclusion criteria
We were interested in randomised controlled trials (RCTs),
which investigated interventions designed to deliver or enhance
holistic care (defined as addressing needs within at least three of
physical, psychological, social or spiritual domains [7]) for patients
with severe COPD in any healthcare context. The intervention
could be part of a wider intervention (e.g. pulmonary rehabilita-
tion or integrated care) if it satisfied the definition of a holistic
intervention and measured an outcome of interest. Definitions of
severe COPD were either a forced expiratory volume in one
second (FEV1) ,50%, or significant breathlessness (e.g. an MRC
Dyspnoea score of 4 or 5), or an admission with an exacerbation of
COPD, or identified by a clinician as being ‘at risk of dying’ from
COPD. We also included quasi-RCTs and controlled clinical trials
(CCTs) as preliminary searches suggested that there would be very
few RCTs. Although our primary outcome of interest was an
improvement in (disease-specific or generic) health-related quality
of life (HRQoL) we were also interested in other measures of
physical, psychological, spiritual and social well-being, health and/
or social service resource use.
Search strategy
We searched 11 international databases for published material:
AMED; British Nursing Index; CINAHL; Cochrane Library;
DARE; EMBASE; ISI Web of Science; LILACS; MEDLINE;
PsycINFO; ZETOC. (The search terms are detailed in Table S1).
In addition, we searched Internet-based international trial
repositories www.clinicaltrials.gov; www.controlled-trials.com and
the UK Clinical Research Network Study Portfolio; and contacted
international experts in order to locate unpublished and on-going
work (see Table S2). Our searches covered a 22-year period from
January 1990 to March 2012. Early work identifying the lack of
supportive care services for people with very severe COPD, [6]
and the wider agenda of extending palliative care to people with
non-malignant disease, [2,6,13] date from the late 1990s so we
judged that intervention studies would be unlikely before 1990;
our preliminary scoping of the literature confirmed this (details
available from corresponding author). The bibliographies of all
eligible studies were scrutinised to identify possible additional
studies. No language restrictions were employed.
Selection of studies
After initial screening for obviously ineligible papers (e.g letters,
abstracts, editorials, pharmaceutical trials, basic science, surveys,
observational studies, reviews, discussion pieces etc) a sub-group of
abstracts of potentially eligible studies were scrutinised in detail
and independently reviewed by two researchers (UN, and SB or
MK). Our eligibility criteria defined holistic care as comprising at
least three of the four components (physical, psychological, social
and spiritual), but in order to ensure that we did not overlook
potentially eligible trials because of limited reporting in the
abstract, we only required abstracts to mention two of the
components. The full texts of all potentially eligible studies were
assessed for eligibility against the inclusion criteria by two
reviewers (UN, and SB or MK). Any disagreements were resolved
through discussion, with HP arbitrating if agreement could not be
reached.
Quality assessment
Methodological quality of included studies was independently
assessed (by UN and SB) using the Cochrane Risk of Bias tool (for
RCTs and quasi-RCTs) [24] and the Effectiveness and Practice
Organisation of Care criteria (for CCTs). [26] Bias was assessed in
the domains of: adequate sequence generation; allocation
concealment; blinding of participants and personnel; blinding of
outcomes; addressing of incomplete data; absence of selective
reporting; absence of other sources of bias. Each parameter and
the overall study was graded: low, moderate or high risk of bias.
Disagreements between the reviewers were resolved by discussion,
with arbitration by HP if needed.
Data extraction
Data were independently abstracted by two reviewers (UN and
SB) onto a customised data extraction sheet. We wrote to authors
of all the papers to clarify any details relating to the intervention or
data which were unclear from the published report. We treated a
study with multiple reports as a single study, but drew on all
relevant publications.
Data synthesis
Based on our preliminary scoping work, we anticipated that we
would identify a limited number of eligible trials with substantial
heterogeneity so that meta-analysis would not be appropriate. We
therefore planned to undertake a narrative synthesis by extracting
data about the elements of the interventions under the headings of
setting, mode of delivery, aspects of holistic care addressed,
duration and intensity of components and the effectiveness (or not)
of the intervention. Interpretation was facilitated by discussion
amongst the multidisciplinary study team.
Holistic Interventions for COPD: Systematic Review
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Results
We identified 2,866 potentially relevant publications, from
which we identified three papers that satisfied our inclusion criteria
(see Figure 1 for the PRISMA flow diagram). We did not identify
any unpublished or studies in progress. The responses from the
experts whom we contacted did not identify any further studies.
The three studies included a total of 216 people with COPD
(see Table 1). Two studies were RCTs [27,28] (one from USA [27]
and one from Australia [28]). One of the RCTs [27] included
patients with COPD or chronic heart failure (CHF) and reported
sub-group analysis for some of the outcomes: the author responded
to our request for further information, but was unable to provide
results for any additional outcomes in the COPD group. The third
study was a CCT, carried out in Thailand. [29] The authors
responded to our request for additional details of the methods.
Description of the interventions
All the interventions were led by nurses acting in a co-
ordinating or case-management role, though context and tasks
varied. (See Table 1 for details)
N Aiken et al., [27] reported the impact of the ‘PhoenixCare’
intervention, [30] which provided integrated case-manage-
ment for patients with either COPD or CHF who had an
estimated life expectancy less than two years. The service was
developed and overseen by a palliative care provider, but
operated within the patients’ managed care organisation
(MCO). A nurse case-manager, supported by a team (medical
director, social worker, counsellor) provided care which had
four foci: self-management of illness and knowledge of
resources, preparation for end of life, physical and mental
functioning, and utilisation of medical services. The control
group received ‘usual care’ which could include case-
management according to normal practice in the MCO.
Figure 1. PRISMA flow diagram.
doi:10.1371/journal.pone.0046433.g001
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N Egan et al. [28] reported a hospital-based intervention,
comprising respiratory nurse-led case-management of patients
during and after an admission with an exacerbation of COPD
in a private hospital in Brisbane, Australia. The intervention
included comprehensive assessment at admission, a pre-
discharge case-conference, and telephone follow-up at one
and six weeks post-discharge. All four aspects of holistic care
were well addressed. Patients in the control group received
usual care with no contact with the case-manager, no case-
conferences, and no post-discharge follow-up.
N Noonill et al. [29] described ‘Community Care for COPD’, a
community-based intervention within tambons (administrative
sub-districts of Thailand). The concept was developed from
community-based pulmonary rehabilitation and promotion of
exercise was an important focus of both the intervention and
outcomes. Delivery was nurse-led and embraced co-ordination
of care for patients with severe COPD, underpinned by a
theoretically-based intervention, [31] which focussed on
mobilisation of community resources including recruiting lay
community health volunteers, systematic education and
integrating positive health changes into lifestyle. Apart from
spiritual support, all other components of holistic care were
well addressed. The control group of patients had usual care;
described as (often distant) hospital-based acute care with
‘limited chronic care for COPD patients’.
Table 1. Characteristics of included studies.
Study, year Country, setting
Patient
demographics
Description of the
delivery of
intervention
Aspects of holistic
care addressed
Duration and
intensity of
components Control
Aiken et al., 2006 [27] Arizona, USA. Hospice-
based community nurse
led case management in
addition to the patients’
usual Managed care
Organisation (MCO)
services
Hypoxic (oxygen
saturation ,88% on
air) sub-group of
COPD patients; with
an estimated 2 year
life expectancy.
Demographics not
reported for the
COPD sub-group.
Study included a
total of 192 patients
with CHF and COPD:
34 COPD patients
received the
intervention, 28
controls.
‘PhoenixCare’:
Intensive home-based
care provided by nurse
case managers. Team
members included
medical director, social
worker and pastoral
counsellor in
association with
primary care physician,
health plan case
manager (if available),
patient/family and
community agencies.
All four components
well addressed.
Physical: Medical
management,
emergency response
plan, disease and
health education.
Psychological and
emotional support
and counselling.
Social Disease and
health promotion
addressing patient
and family
understanding of
the disease,
Community resource
referrals. Spiritual
Assessment and
review of spiritual
concerns. Advance
Care Planning
discussions
Intensive programme
of home visits/calls,
with an average of
44 contacts ‘over
course of the
intervention’. Duration
of the intervention
unclear with most
outcomes reported at
3 and 6 months, but
some at 9 months.
Contacts increased in
the event of an
exacerbation.
Usual MCO
management
(which could
include ‘usual’ case
–management)
Egan et al., 2002 [28] Brisbane, Australia.
Hospital-based, nurse-
led case management
in a large private
hospital
Patients with COPD
and/or chronic
asthma during an
admission to hospital.
48% male, Mean age
67 years. 33 patients
received the
intervention, 33
controls.
Respiratory nurse-led
case management
during admission with
an exacerbation
including assessment
on admission, case-
conference before
discharge, and
telephone follow-up
at 1 and 6 weeks
post-discharge.
All four components
well addressed. ‘‘A
comprehensive
nursing assessment
identified physical,
psychological, social,
spiritual and resource
needs’’
Intense programme
of care during
admission; with
contacts at 1 and 6
weeks after discharge.
Usual inpatient care
Noonill et al., 2007 [29] Thasala,
Thailand.Community-
based, nurse led
intervention within
tambons (administrative
sub-districts)
Patients with COPD
with no significant
co-morbidities and
who had a support
person willing to
participate in the
study living nearby.
83% male aged 70
years (SD 6); 44
patients received the
intervention, 43
controls
‘Community Care for
COPD’. Community
nurse-led co-ordination
of care focussing on
mobilisation of
community resources,
systematic education,
integrating positive
health lifestyle
changes.
Three components
well addressed.
Physical: intervention
built around concept
of pulmonary
rehabilitation
Psychological:
‘enhanced
psychosocial support
from the community
nurse Social: key
focus on mobilising
community support
(visits from health
volunteers and family
supervision)
Programme
implemented over 12
weeks. Monthly visits
by community nurse
supplemented by
community support
including twice-
monthly visits from
lay community health
volunteers as well as
family and community
supervision
Usual hospital
based acute care
with ‘limited’
chronic care.
‘Largely
inaccessible’
respiratory clinics.
doi:10.1371/journal.pone.0046433.t001
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Methodological quality
The results of the quality assessment are detailed in Table 2.
Concerns about selective reporting of outcomes (and domains
within patient-reported outcomes) resulted in Aiken 2006 being
judged at moderate risk of bias. [27] Egan 2002 was judged at high
risk of bias because of lack of information about blinding of
researcher, and the handling of incomplete datasets. [28] Noonill
et al. was, after substantial clarification by the authors of the
process of randomisation and blinding of the researchers, judged
at moderate risk of bias. [29]
Effectiveness of interventions
The findings of the studies are detailed in Table 3.
Health-related quality of life. The impact on quality of life
varied in the three trials. Noonill et al. [29] reported that at three
months HRQoL measured with the St George’s Respiratory
Questionnaire (SGRQ) [32] was significantly better in the patients
from the intervention compared to control tambons, though no
allowance was made for cluster effects (intervention group: 30.3
(19.4), control group: 52.4 (21.3) p,0.001). [29] This difference is
substantially greater than the minimum clinically important
difference for the SGRQ of four. [32] Aiken et al. reported that
the rate of decline over nine months in two domains (‘Physical
functioning’ and ‘General health’) of the Medical Outcomes Study
Short-Form-36 Health Survey (SF-36) [33] was less in the
PhoenixCare group than in the control group, though there was
no significant difference in the other domains, or at 6-months. [27]
Egan et al. observed no significant difference in the SGRQ at one
month (Median change: intervention: 21.6 vs control 21.5
p= 0.621) as a result of in-patient case-management. [28]
Other outcomes: measures of physical, psychological,
spiritual and social well-being. The outcome measures
reported by Noonill et al. reflect the exercise component of the
‘Community Care for COPD’ and significant improvement was
seen at 3-months in both the 6-minute walking test (6MWD) [34]
(intervention: 342.8 (106.1) vs control: 265.1 (94.4) p = 0.001) and
the Dyspnoea Visual Analog Scale [35] (intervention: 4.5 (2.2) vs
control: 6.2 (1.8) p = 0.000). Aiken et al. reported that mean
symptom distress (part of the Memorial Symptom Assessment
Scale [36]) was significantly lower in the PheonixCare intervention
group than in controls at 3-months (mean 3.41 vs 4.29 on a 5-
point scale, p,0.05). There was no significant difference at 6-
months, or in the frequency or severity of symptoms at either time
point. [27]
Psychological well-being was reported by Egan et al. [28], who
reported no significant differences in subjective well-being, or
anxiety and depression at one month. The ‘affectionate support’
domain of the Social Support Survey [37] however showed a
significant difference (Median change intervention: 26.7 vs
control 0.0 p= 0.034). Aiken et al. [27] used 11 non-validated
questions to assess the impact of the PhoenixCare intervention on
self-management of illness and resumption of activities, but only
reported two for the COPD sub-group which showed small
significant differences at 3-months, but which were not sustained
to 6-months.
Health and/or social service resource use. None of the
trials showed a difference in health service utilisation, [27,28,29]
though Aiken et al. did not report data for the COPD sub-group.
[27]
Satisfaction with care. Noonill et al. [29] measured patient
satisfaction with the validated Patient Satisfaction with Care
(PSCQ). [38] At 3-months patients in the tambons which received
the ‘Community Care for COPD’ intervention were significantly
more satisfied than the controls (intervention: 91.1 (10.7) vs
control: 74.9 (15.4) p,0.001). [29] Egan et al. undertook a nested
qualitative study and concluded that there was a perceived
improvement in access to resources and communication which
enhanced patient care. [28]
Discussion
We found three controlled trials of holistic interventions
designed to deliver or enhance supportive care for people with
severe COPD. All the interventions involved nurse-led case-
management/co-ordination roles. The two RCTs, however, were
either small studies, [28] included COPD as a sub-group, [27]
were at risk of bias because of selective reporting, [27] or lack of
blinding of researchers. [28] The CCT of co-ordinated community
support in Thailand showed the most consistent effect (but follow
up was only three months) in terms of improved HRQoL, exercise
tolerance, dyspnoea, and satisfaction with care compared to the
very low level of support available to the control group (though no
allowance was made for cluster effects). [29] The impact of the
PhoenixCare intervention in the American trial was confined to
sub-domains of outcome measures and transient: [27] the
Australian intervention showed no significant benefit. [28] There
is, thus, a lack of robust evidence to inform the design of holistic
interventions to support people living with severe COPD.
Strengths and limitations
We searched a broad range of published and unpublished
sources, and reassuringly no further studies were highlighted by
the panel of international experts. Nevertheless we may have
overlooked some relevant work. Our focus on RCTs meant that
we did not, for example, include observational studies. We would
have missed trials published prior to 1990, though this is unlikely
as observational and qualitative studies identifying the problem
only appear in the literature from the late 1990s. [2,6,13] We
excluded studies that provided holistic care for patients with a
range of advanced non-malignant disease, unless they reported
outcomes for a sub-group people with COPD: some of these
studies might have been informative though they could not address
our specific question. We imposed no language or geographical
restrictions on included studies.
A key challenge for the review was the definition of a ‘holistic
intervention’. We defined this as an intervention which included at
least three of the components of supportive care (physical,
psychological, social and spiritual), but recognised that the tight
word count of an abstract might preclude adequate description. In
order not to risk rejecting potentially eligible studies at abstract
stage we therefore reviewed the full paper if the abstract alluded to
two or more domains, only excluding them if the full text did not
explicitly describe three domains.
Interpretation of findings in relation to previously
published work
The common concept underpinning the interventions described
in the three papers included in our review was the nurse-led co-
ordination of services described in two of the studies as ‘case-
management’. [28,29] Interpretation of this concept varied
according to context. In the USA, the PhoenixCare Programme
integrated with the existing MCOs: an approach which has been
shown to improve HRQoL in the frail elderly, [39,40,41] improve
patient satisfaction in groups with a range of life-threatening
conditions, [42,43] though impact on use of healthcare resources is
variable. [44] In Thailand, the study which showed the most
consistent improvement, the nurse co-ordinator not only provided
individual specialist care for patients but also catalysed lay
Holistic Interventions for COPD: Systematic Review
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community support which aimed to encourage greater levels of
activity by integrating people potentially isolated by their
breathlessness into the community. The role of the voluntary
sector may have relevance for other societies in the form of local
patient support groups, [45] and more broadly in terms of
community support. [46]
The impact of a complex intervention depends as much on the
nature of the care provided to the control group as on the
Table 3. Main findings and interpretation.
Health-related
quality of Life
Measures of physical,
psychological, spiritual and
social well-being
Health and/or social
service resource use Satisfaction with care Interpretation
Aiken et al. [27] SF-36 mean differences
not reported for COPD
sub-group. Growth curve
modeling of functional
status over time was
reported for domains of
SF-36 for the COPD sub-
group. Physical
functioning at baseline:
13.0. change at 9
months: intervention
+1.00 vs control 20.95
p,0.05. General health
at baseline: 17.4.
change at 9 months:
intervention: +0.54 vs
control 21.67 p,0.05.
No significant
differences in the
other domains.
2 (of 11) non-validated questions
with significant differences at 3
months (no difference at 6 months)
were reported for COPD sub-group:
‘Begun or resumed an enjoyable
activity in the previous 4 weeks’
Intervention 63% vs control 16%
p= 0.01. ‘Experienced an event in
the previous 4 weeks for which he/she
felt unprepared’ Intervention 32% vs
control 58% p,0.05 Mean frequency,
severity and distress of the most
troublesome symptom (part of the
MSAS) was reported for COPD
patients: Mean symptom distress
was significantly lower in the
intervention group than in controls
at 3 months (mean 3.41 vs 4.29 on a
5-point scale, p,0.05). No significant
difference at 6 months, or for
frequency or severity of symptom at
either time point
Medical system
utilization (including
hospitalisation) not
reported for the COPD
sub-group, though
there was no difference
in the combined group
Number of months in
programme not
reported for COPD
patients, though
attrition in the
combined group is
reported as ‘At the end
of data collection 44%
of the PhoenixCare
participants and 25% of
control patients were
still participating’
There was some evidence
that the PhoenixCare
intervention had a small,
transient effect on
selected domains of
quality of life and distress
due to breathlessness.
Egan et al. [28] No significant difference
in the SGRQ at 1 month:
Median change
intervention: 21.6 vs
control 21.5 p = 0.621
There were no significant
differences in SWB (Median change
intervention: 2.8 vs control 22.8
p = 0.416), HADS anxiety (Median
change intervention: 21.0 vs
control 22.5 p = 0.437) HADS
depression (Median change
intervention: 0.5 vs control 21.0
p = 0.383). The ‘affectionate
support’ domain of the SSS
showed a significant difference
(Median change intervention:
26.7 vs control 0.0 p = 0.034
The mean number
of unscheduled
readmissions for the
intervention group
patients was 2.1 and
for control group
patients was 2.6
Qualitative data
suggested the
intervention was
perceived to improve
access to resources
and communication
(staff-patient and
staff-staff).
Case management of
inpatients did not improve
quality of life, or anxiety
and depression
Noonill et al. [29] SGRQ at 3 months:
intervention: 30.3 (SD
19.4) vs control 52.4
(21.3) p,0.001. Scores
for control group at
baseline not given.
Improvement of 20.1
in total SGRQ score
(minimal clinical
important difference 4)
6MWD at 3-months: intervention:
342.8 (106.1) vs control: 265.1
(94.4) p = 0.001. Dyspnoea VAS
at 3-months: intervention: 4.5 (2.2)
vs control: 6.2 (1.8) p = 0.000
Hospitalisation in
previous 3-months 3/43
(7.0) 2/44 (4.5) p = 0.651
PSCQ at 3 months
(intervention: 91.1 (10.7)
vs control: 74.9 (15.4)
p,0.001)
When compared to the
limited community care
available to people with
COPD in Thailand, the
‘Community Care for
COPD’ intervention’
resulted in highly
significant improvements
in quality of life,
breathlessness, exercise
tolerance, though no
impact on hospitalisation.
[No allowance for
clustering effects]
6MWD - Six-minute walk distance measures the distance a patient can walk quickly on a flat, hard surface in 6 minutes reflects ability to perform daily activities, [34]
Dyspnoea VAS - Dyspnoea Visual Analog Scale, measures breathlessness in the sensory-perceptual domain [35].
HADS – Hospital Anxiety and Depression Score. Scores $11 indicate significant anxiety or depression; #7 are normal. [53]
MSAS - Memorial Symptom Assessment Scale assesses symptom prevalence, characteristics and distress. [36]
PSCQ - Patient satisfaction with care questionnaire reflects satisfaction with six aspects of care: technical quality, interpersonal manner, communication, financial aspects
of care, time spent with doctor, and accessability of care. [38]
SF-36 - Medical Outcomes Study Short-Form-36 Health Survey is a generic health status measure with two summary measures of physical and mental health
constructed from the eight scales. [33]
SGRQ – St George’s Respiratory Questionnaire measures symptoms, activities and impacts on a scale: 0 to 100 (greatest impairement); with a minimum clinically
important difference of 4). [32]
SSS - Social Support Survey has four functional support scales (emotional/informational, tangible, affectionate, and positive social interaction) and the construction of an
overall social support index. [37]
SWB - Subjective Well-Being Scale is a longitudinal measure of the quality of life of patients with metastatic, incurable cancer. [54]
doi:10.1371/journal.pone.0046433.t003
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effectiveness of the intervention. In Thailand, where the usual care
was very limited, [29] the intervention had a substantial impact (on
activities and quality of life, though not admissions) whereas
comparison with the care provided by an MCO which could
include case-management may offer less scope for improvement.
[27]
Implications for policy, practice and research
A key consideration for developing and evaluating interventions
is the choice of outcome measures. [47] Costly admissions may be
the outcome of interest to healthcare planners, whereas in order to
assess the wider impact of an intervention, HRQoL may be more
appropriate. Specific symptoms such as breathlessness may be a
key problem, [19] but for a potentially isolated housebound
patient the resultant social concerns may be paramount. The
range of outcomes used both in the studies we reviewed and more
widely in the literature on management of severe COPD,
[48,49,50,51,52] may be symptomatic of the challenge of
evaluating a broad holistic intervention as effects may be expected
to be diverse and the most appropriate primary outcome may not
be apparent. There may be value in reaching consensus about core
outcomes for trials in this area in order to facilitate future synthesis
of evidence.
Conclusions
Some 15 years after the early reports highlighting the unmet
needs of people with severe COPD, [2,13] we have been unable to
find robust evidence about interventions which can address those
needs. Globally, over the next two decades the number of people
living with, and potentially dying from COPD is predicted to
increase substantially, [1] but healthcare services seeking to
develop services to meet this challenge currently have little
evidence on which to base their decisions. There is, thus, an urgent
need rigorously to develop and evaluate interventions designed to
deliver or enhance holistic care and improve quality of life of
people with severe COPD.
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